However, It Seems No Further Research About This Congenital Birth Defect Being Caused By Zofran Use During Pregnancy Has Been Done By GlaxoSmithKline
SUMMARY: For many years now, some women with morning sickness have been prescribed Zofran (ondansetron) and had babies born with birth defects and other congenital malformations.
As far back as 2004 some medical researchers have noted that while Zofran is being used for morning sickness there have been no sufficient medical studies examining its safety in pregnancy.
While the lack of a sufficient Zofran pregnancy-use safety study was certainly pointed out by the authors of that 2004 medical journal article, and they identified hypospadias as a specific “major malformation” which might be associated with Zofran use, it seems that little if any such safety research has been done by the drug company GlaxoSmithKline to date — despite those authors’ clear call for such.
We are currently investigating possible drug injury lawsuits against GlaxoSmithKline for cases where Zofran used by pregnant women resulted in birth defects, congenital malformations, or deformities in children born to those women.[Read this article in full at original source]
Strictly Confidential, No Obligation